select a format

Single User License
USD 250 INR 16213
Site License
USD 500 INR 32425
Corporate User License
USD 750 INR 48638

Alternatively

Request a quote
Request a Customized research
Request for Sample Report





Recent Viewed Reports


Why Ken Reasearch?


Testimonials

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ... "Mohit Mittal, Consultant, KPMG Advisory Services"

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies.... "Mustafa Masood, Financial Analyst , Coldwell Banker Riyadh"

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ... "Prashant Bhagwat,General Manager, Mahindra"

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!... "Jestin Mathew, Indonesian Trade Promotion Center"

The Report was very interesting and useful for me... "Marketing Manager, Western Union Business Solutions"


Trevena Inc (TRVN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Trevena Inc (TRVN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


  • Products Id :- GDPH135526D
  • |
  • Pages: 41
  • |
  • May 2017
  • |
  • |
  Request for Sample Report

Executive Summary

Summary

Trevena Inc (Trevena) is a biopharmaceutical company that discovers and develops G-protein coupled receptor targeted medicines. The company's products include RV027, TRV130, TRV734 and TRV250. Its TRV027 is an intravenous drug used for the treatment of acute heart failure in combination with standard diuretic therapy. Trevena's TRV130 is an intravenous G protein biased ligand that targets the mu opioid receptor. The company's GPCR is associated with beneficial versus adverse biological effects. Its TRV250 is an oral delta opioid biased ligand for treatment of refactory migraine. Trevena is headquartered in King of Prussia, Pennsylvania, the US.

Trevena Inc (TRVN)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications
ankur [@] kenresearch.com
+91-9015378249
www.kenresearch.com

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Trevena Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Trevena Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Trevena Inc, Pharmaceuticals & Healthcare, Deal Details 11

Venture Financing 11

Trevena To Raise US$60 Million In Series C Financing 11

Partnerships 12

Trevena Enters Into Research Agreement With Merck For Biased Ligand Molecules 12

Licensing Agreements 13

Trevena Enters Into Option Agreement With Forest Labs To License TRV027 13

Equity Offering 14

Trevena Raises USD73 Million in Public Offering of Shares 14

Trevena Raises USD51.4 Million in Public Offering of Shares 15

Trevena Completes Underwriters Exercise Of Over-Allotment Of IPO For US$66.6 Million 17

Trevena Inc-Key Competitors 20

Key Employees 21

Locations And Subsidiaries 22

Head Office 22

Recent Developments 23

Financial Announcements 23

May 04, 2017: Trevena Reports First Quarter 2017 Financial Results and Provides Corporate Update 23

Mar 08, 2017: Trevena Reports Full Year 2016 Earnings 24

Nov 03, 2016: Trevena Reports Third Quarter 2016 Financial Results and Provides Corporate Update 26

Aug 04, 2016: Trevena Reports Second Quarter 2016 Financial Results and Provides Corporate Update 27

May 05, 2016: Trevena Reports First Quarter 2016 Financial Results and Provides Corporate Update 28

Mar 09, 2016: Trevena Reports Full Year 2015 Financial Results 29

Product News 31

10/27/2016: Trevena Announces Highlights from Recent Presentations 31

Product Approvals 32

Feb 22, 2016: Trevena Receives FDA Breakthrough Therapy Designation for Oliceridine 32

Clinical Trials 33

Apr 06, 2017: Trevena Announces Presentations at the 42nd Annual Regional Anesthesiology and Acute Pain Medicine Meeting 33

Feb 21, 2017: Trevena Announces Positive Top-line Results from Two Phase 3 Pivotal Efficacy Studies of Intravenous Oliceridine in Moderate-to-Severe Acute Pain 35

Jan 04, 2017: Trevena Completes Enrollment of Phase 3 APOLLO Pivotal Efficacy Trials of Oliceridine for Moderate-to-Severe Acute Pain 37

Jun 08, 2016: Trevena Announces First Patients Enrolled in the APOLLO-1 and APOLLO-2 Phase 3 Pivotal Efficacy Studies of Oliceridine in Acute Pain 38

May 02, 2016: Trevena Announces Successful End-of-Phase 2 Meeting with FDA and Outlines Phase 3 Program for Oliceridine 39

Jan 19, 2016: Trevena Announces Initiation of Oliceridine Phase 3 Clinical Program 40

Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41

List of Figures

Trevena Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Trevena Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

List of Tables

Trevena Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 1

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Trevena Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Trevena Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Trevena Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Trevena Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10

Trevena To Raise US$60 Million In Series C Financing 11

Trevena Enters Into Research Agreement With Merck For Biased Ligand Molecules 12

Trevena Enters Into Option Agreement With Forest Labs To License TRV027 13

Trevena Raises USD73 Million in Public Offering of Shares 14

Trevena Raises USD51.4 Million in Public Offering of Shares 15

Trevena Completes Underwriters Exercise Of Over-Allotment Of IPO For US$66.6 Million 17

Trevena Inc, Key Competitors 20

Trevena Inc, Key Employees 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Trevena Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Ken Research Pvt. Ltd. 27A, Tower B-2, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India
+91 1244230204

download

Company Brochure

Engage with Us

query [@] kenresearch.com